M&A Deal Summary

BTG Acquires Galil Medical

On May 6, 2016, BTG acquired medical products company Galil Medical for 85M USD

Acquisition Highlights
  • This is BTG’s 3rd transaction in the Medical Products sector.
  • This is BTG’s 2nd largest (disclosed) transaction.
  • This is BTG’s 2nd transaction in the United States.
  • This is BTG’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2016-05-06
Target Galil Medical
Sector Medical Products
Buyer(s) BTG
Deal Type Add-on Acquisition
Deal Value 85M USD
Advisor(s) Houlihan Lokey (Financial)
Fredrikson & Byron
Raved Magriso Benkel & Co.
Willkie Farr & Gallagher (Legal)

Target

Galil Medical

Arden Hills, Minnesota, United States
Galil Medical, Inc. is a provider of medical products for cryoablation solutions.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BTG

London, United Kingdom
Category Company
Founded 1948
Sector Medical Products
Employees1,182
Revenue 823M USD (2018)
DESCRIPTION

BTG plc which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceuticals. BTG has three key businesses, the largest of which is its Interventional Medicine portfolio which encompasses several peripheral interventional product lines. The interventional oncology franchise includes the TheraSphere® Y-90 radiotherapy microspheres and the GALIL™ cryoablation system, used to treat patients with liver, kidney, and other cancers. More than 840,000 people are expected to be diagnosed with liver cancer in 2018, and that number is expected to grow to 1.1 million by 2030. Kidney cancer is among the 10 most common cancers in both men and women.

DEAL STATS #
Overall 4 of 6
Sector (Medical Products) 3 of 5
Type (Add-on Acquisition) 2 of 4
State (Minnesota) 1 of 1
Country (United States) 2 of 4
Year (2016) 1 of 1
Size (of disclosed) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-04 PneumRx

Mountain View, California, United States

PneumRx, Inc. is a medical device company focused on the development and commercialization of innovative products to treat emphysema using minimally invasive techniques. PneumRx was formed in 2004 and is based in Mountain View, California.

Buy $475M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-10-05 Roxwood Medical

Redwood City,, California, United States

Roxwood Medical, Inc. is an innovative provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease. Roxwood's anchoring catheters (CenterCross®, CenterCross® Ultra, MultiCross®) and microcatheters (MicroCross®) offer options for physicians in the crossing of complex lesions and arterial blockages.

Buy $80M
Mergr

Product

Company

Legal